Together with these developments, our observations in the spheroid assay call for and justify follow-up studies to combine Hsp27 inhibitors with HT + RT in HNSCC 3-D models in vitro and, even more importantly, in vivo. Here, HSPB1 is linked to head and neck squamous cell carcinoma.